SEC filings · customer concentration

Who depends on SK Bioscience

SK Bioscience appears in 1 disclosed customer relationships between 2021 and 2024.

0major customers now
—of revenue from them
0listed suppliers depending on it
2021–2024years covered
Free

Get an email when SK Bioscience's customer concentration changes

When a new annual report adds a 10% customer, drops one, or moves a share by 5 points or more, you get the change and the filing link. Up to 10 companies per address, no account, unsubscribe with one click.

Suppliers that depend on SK Bioscience

Listed companies whose annual report names SK Bioscience as a customer worth 10% or more of their revenue. If SK Bioscience cuts orders or switches supplier, these are the companies that feel it.

Formerly disclosed

SupplierIts revenue from this companyChange vs prior yearHistoryLatest filing
NovavaxNVAX14%last FY 2021FY 2021: 14%1 yearFY 2021 · filed 28 Feb 2024

About this data

US-listed companies must disclose revenue from any single customer that reaches 10% of their total (ASC 280). ShadowGraph reads these disclosures from the XBRL data of every 10-K and 20-F we scan, keeps one value per fiscal year (restatements replace earlier values) and links each number to its filing. Companies that describe a customer only as "Customer A" are not listed by name. Figures are as reported; nothing here is investment advice.

All companies · Latest dependency shifts · Bulk data and API